CD19 and B-cell chronic lymphocytic leukemia: Moreover, patients with CLL also had significantly reduced levels of CD19+IgM−IgD−CD38lowCD27+ class switched memory B cells (30.43 ± 6.39) when compared to the control group (58.99 ± 6.99), p < 0.0001 (Fig. 2H).